| |
|
|
|
Fulgent Genetics Inc.  
|
|
11.51 0.14 (0.01%) |
10-18 16:00 |
|
Open: |
11.38 |
Pre close: |
11.37 |
Target:
|
14.45
|
|
High: |
11.6199 |
Low: |
11.17 |
Resistance:
|
12.37
14.45
|
|
Volume: |
69,081 |
Market Cap: |
213M |
Support:
|
10.76
9.77
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
11.28
 |
MACD |
MACD(12,26):
|
0.11 |
|
MA(20): |
11.08 |
Signal(12,26,9): |
0.10 |
|
MA(100): |
8.91 |
Stochastic Oscillator |
%K(14,3):
|
61.15 |
|
MA(250): |
6.35 |
%D(3): |
57.65 |
|
Average Volume(K) |
3-Month: |
9801
|
52-Week |
High:
|
12.88 |
|
10-Days: |
6133 |
Low: |
3.02 |
|
RSI |
RSI(14):
|
54.89 |
Change(%): |
218.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.230 |
Return on Equity (ttm) |
-8.1 |
Shares Out. (M) |
18.49 |
|
EPS Est. Current Year |
0.140 |
Return on Assets (ttm) |
-3.8 |
Shares Float (M) |
8.41 |
|
EPS Est. Next Year |
0.320 |
PEG Ratio |
4.48 |
% Held by Insiders |
68.90 |
|
EPS Est. Next Quarter |
0.070 |
Qtrly Rev. Growth |
56.0 |
% Held by Institutions |
6.74 |
|
Forward EPS |
0.070 |
Gross Profit (p.s.) |
0.576 |
Shares Short (K) |
108 |
|
Book Value (p.s.) |
2.780 |
EBITDA (p.s.) |
-0.069 |
P/E |
-50.04 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.14 |
|
Profit Margin |
-16.84 |
Operating Cash Flow
(M) |
2.40 |
P/S |
154217312.00 |
|
Operating Margin |
-13.56 |
Levered Free Cash Flow
(M) |
0.02 |
P/CF |
88.67 |
|
|
|
|
|
|
